In conclusion, this study has provided new insights into the complexity of RasGAP and KRAS signaling, and reveals a novel role for RasGAP as an effector of KRAS and Rho pathway activity in colorectal cancer. This evidence concerns the gene RASA1 and colorectal cancer.